SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 1.56 |
Enterprise Value ($M) | 0.64 |
Book Value ($M) | -0.13 |
Book Value / Share | -0.15 |
Price / Book | -12.22 |
NCAV ($M) | -1.75 |
NCAV / Share | -2.05 |
Price / NCAV | -0.89 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -21.52 |
Return on Assets (ROA) | -1.34 |
Return on Equity (ROE) | -2.79 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.72 |
Current Ratio | 0.72 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 3.64 |
Assets | 5.26 |
Liabilities | 5.39 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -13.48 |
Net Income | -19.94 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Nonrecurring Common Control Intra Entity Transactions Description | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -10.92 |
Cash from Investing | 0.00 |
Cash from Financing | 5.91 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Armistice Capital, Llc | 9.99 | ||
13D/A | Feldmann Marc | 3.40 | -95.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
2,068 | 18,816 | 10.99 | |
19,614 | 87,287 | 22.47 | |
121,996 | 38,290 | 318.61 | |
109,906 | 99,694 | 110.24 | |
5,432 | 2,163 | 251.13 | |
(click for more detail) |
Similar Companies | |
---|---|
ARTL – Artelo Biosciences, Inc. | ASNS – Actelis Networks, Inc. |
ASRT – Assertio Holdings, Inc. | ATOS – Atossa Therapeutics, Inc. |
ATXI – Avenue Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io